Jacobs Solutions Inc.: Form 10-Q for the period ended Mar 28, 2025
Filed with the SEC on May 6, 2025 and accepted by EDGAR at May 6, 2025, 06:50 ET.
Management's discussion and analysis
As filed, 2,295 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
There were no sales of unregistered securities during the second fiscal quarter of 2025.
Share Repurchases
On January 25, 2023, the Company's Board of Directors authorized a share repurchase program of up to $1.0 billion of the Company's stock, to expire on January 25, 2026 (the "2023 Repurchase Authorization").
On January 30, 2025, the Company's Board of Directors authorized an incremental share repurchase program of up to $1.5 billion of the Company's common stock, to expire on January 30, 2028 (the "2025 Repurchase Authorization").
An aggregate summary of repurchases of the Company’s common stock made during the second quarter of fiscal 2025 under the 2023 Share Repurchase Authorization and the 2025 Share Repurchase Authorization follows:
| Period | Total Number of Shares Purchased | Average Price Per Share (1) | Total Number of Shares Purchased under the 2023 and 2025 Repurchase Authorizations | Approximate Dollar Value of Shares that May Yet Be Purchased Under the 2023 and 2025 Repurchase Authorizations |
|---|---|---|---|---|
| December 28, 2024 - January 24, 2025 | 392,787 | $135.59 | 392,787 | $217,531,896 |
| January 25, 2025 - February 21, 2025 | 494,266 | $134.40 | 494,266 | $151,103,572 |
| February 22, 2025 - March 28, 2025 | 1,837,345 | $125.77 | 1,837,345 | $1,420,011,932 |
| Total | 2,724,398 | 2,724,398 |
(1) Includes commissions paid and excise tax due under the Inflation Reduction Act of 2022 and calculated at the average price per share.
Our share repurchase program does not obligate the Company to purchase any shares. Share repurchases may be executed through various means including, without limitation, accelerated share repurchases, open market transactions, privately negotiated transactions, purchases pursuant to Rule 10b5-1 plans or otherwise. The authorization for the share repurchase programs may be terminated, increased or decreased by the Company’s Board of Directors in its discretion at any time. The timing, amount and manner of share repurchases may depend upon market conditions and economic circumstances, availability of investment opportunities, the availability and costs of financing, currency fluctuations, the market price of the Company's common stock, other uses of capital and other factors.
Market risk
As filed, 3,665 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
We do not enter into derivative financial instruments for trading, speculation or other similar purposes that would expose the Company to market risk. In the normal course of business, our results of operations are exposed to risks associated with fluctuations in interest rates and currency exchange rates.
Interest Rate Risk
Please see the Note 12- Borrowings in Notes to Consolidated Financial Statements appearing under Part I, Item 1 of this Quarterly Report on Form 10-Q, which is incorporated herein by reference, for a discussion of the Revolving Credit Facility, Term Loan Facility and Note Purchase Agreement.
Our Revolving Credit Facility, 2025 Term Loan Facility and certain other debt obligations are subject to variable rate interest which could be adversely affected by an increase in interest rates. As of March 28, 2025, we had an aggregate of $1.54 billion in outstanding borrowings under our Revolving Credit Facility and 2025 Term Loan Facility. Interest on amounts borrowed under these agreements is subject to adjustment based on the Company’s Consolidated Leverage Ratio (as defined in the credit agreements governing the Revolving Credit Facility and the 2025 Term Loan Facility). Depending on the Company’s Consolidated Leverage Ratio, borrowings denominated in U.S. dollars under the Revolving Credit Facility bear interest at a SOFR rate plus a margin of between 0.975% and 1.725% or a base rate plus a margin of between 0.0% and 0.625% including applicable margins while borrowings denominated in British pounds under these respective facilities bear interest at an adjusted SONIA rate plus a margin of between 0.908% and 1.658%. Borrowings under the 2025 Term Loan Facility will bear interest at either a SONIA rate or term SOFR rate plus a margin of between 0.975% and 1.60% or a base rate plus a margin of between 0.0% and 0.50%. Additionally, our Revolving Credit Facility and our 5.90% Bonds have interest rates subject to potential increases relating to certain ESG metrics as stipulated in the related agreements and as discussed in Note 12- Borrowings.
However, as discussed in Note 18- Commitments and Contingencies and Derivative Financial Instruments, we are party to a swap agreement with a notional value of $200.0 million to convert the variable rate interest based liabilities associated with a corresponding amount of our debt into fixed interest rate liabilities, leaving $1.34 billion in principal amount subject to variable interest rate risk. Additionally, during fiscal 2022, we entered into two treasury lock arrangements with an aggregate notional value of $500.0 million, which were settled in the second quarter fiscal 2023, and are disclosed in further detail in Note 18- Commitments and Contingencies and Derivative Financial Instruments.
For the six months ended March 28, 2025, our weighted average borrowings that are subject to floating rate exposure were approximately $1.16 billion. If floating interest rates had increased by 1.00%, our interest expense for the six months ended March 28, 2025 would have increased by approximately $5.8 million.
Foreign Currency Risk
In situations where the Company incurs costs in currencies other than our functional currency, we sometimes enter into foreign exchange contracts to limit our exposure to fluctuating foreign currencies. We follow the provisions of ASC 815, Derivatives and Hedging in accounting for our derivative contracts. The Company has $815.8 million in notional value of exchange rate sensitive instruments at March 28, 2025. See Note 18- Commitments and Contingencies and Derivative Financial Instruments for discussion.
Controls and procedures
As filed, 2,528 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Evaluation of Disclosure Controls and Procedures
Disclosure controls and procedures are those controls and procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) are recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed under the Exchange Act is accumulated and communicated to management, including our Chief Executive Officer (principal executive officer) and Chief Financial Officer (principal financial officer), to allow timely decisions regarding required disclosure.
The Company’s management, with the participation of its Chief Executive Officer (principal executive officer) and Chief Financial Officer (principal financial officer), evaluated the effectiveness of the Company’s disclosure controls and procedures as defined by Rule 13a-15(e) of the Exchange Act defined above, as of March 28, 2025, the end of the period covered by this Quarterly Report on Form 10-Q (the “Evaluation Date”). Based on that evaluation, the Company’s management, with the participation of the Chief Executive Officer (principal executive officer) and Chief Financial Officer (principal financial officer) concluded that the Company’s disclosure controls and procedures, as of the Evaluation Date, were effective to ensure that information required to be disclosed by the Company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and that such information is accumulated and communicated to the Company’s management, including the Company’s Chief Executive Officer (principal executive officer) and Chief Financial Officer (principal financial officer), as appropriate to allow timely decisions regarding required disclosure.
Changes in Internal Control Over Financial Reporting
There were no changes to our internal control over financial reporting which were identified in connection with the evaluation required by paragraph (d) of Rules 13a-15 and 15d-15 under the Exchange Act during the quarter ended March 28, 2025 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Risk factors
As filed, 2,792 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Please refer to Item 1A- Risk Factors in our 2024 Form 10-K, which is incorporated herein by reference, for a discussion of some of the factors that have affected our business, financial condition, and results of operations in the past and which could affect us in the future. There have been no material changes to those risk factors, except for the information disclosed elsewhere in this Quarterly Report on Form 10-Q that provides factual updates to those risk factors and the inclusion of the additional risk factors set forth below. Before making an investment decision with respect to our common stock, you should carefully consider those risk factors, as well as the financial and business disclosures contained in this Quarterly Report on Form 10-Q and our other current and periodic reports filed with the SEC.
Recent international trade issues, including tariffs and counter tariffs, if continued, may have a negative impact on our business generally.
Recently, there have been notable developments in international trade from the imposition of tariffs and counter tariffs in the United States, and in other countries in which we or our customers and suppliers operate. Increases in protectionist measures such as tariffs or import or export licensing requirements, whether imposed by the United States or such other countries, may adversely impact our business by causing a slowdown in global trade and a decrease in government or corporate spending.
These measures may also have the effect of heightening many of the other risks applicable to our business, including risks relating to:
- the impact of inflation and rising interest rates and/or construction costs, particularly on any fixed-price contract, which we may not be able to fully mitigate,
- our failure to meet performance requirements or contractual schedules, including as a result of supply chain disruptions,
- a reduction in the amount of available governmental funding,
- our international operations, including risks of facing backlash from potential customers as a result of being headquartered in the United States, and
- our indebtedness and credit markets.
While tariffs on goods and other trade measures have not yet had a significant impact on our business or results of operations, we are monitoring and evaluating any potential impacts that the imposition of tariffs and other trade measures may have on our business, and considering ways in which we, or our clients, may mitigate the potential impact of such tariffs and other trade measures. There is no assurance that we will be successful in mitigating such impacts. Additionally, we cannot fully predict the further developments that could have a material adverse impact on our business, financial condition and results of operations.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2025-03-28. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2024-12-28 to 2025-03-28 | $2.91bn | us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax |
| Revenue | 6 months2024-09-28 to 2025-03-28 | $5.84bn | us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax |
| Cost of revenue | 3 months2024-12-28 to 2025-03-28 | $2.17bn | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months2024-09-28 to 2025-03-28 | $4.38bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2024-12-28 to 2025-03-28 | $738.3m | us-gaap:GrossProfit |
| Gross profit | 6 months2024-09-28 to 2025-03-28 | $1.46bn | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months2024-12-28 to 2025-03-28 | $529.7m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2024-09-28 to 2025-03-28 | $1.04bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2024-12-28 to 2025-03-28 | $208.6m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2024-09-28 to 2025-03-28 | $417.1m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2024-12-28 to 2025-03-28 | $38.6m | us-gaap:InterestExpenseNonoperating |
| Interest expense | 6 months2024-09-28 to 2025-03-28 | $73.4m | us-gaap:InterestExpenseNonoperating |
| Income tax | 3 months2024-12-28 to 2025-03-28 | $50.6m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2024-09-28 to 2025-03-28 | $107.7m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2024-12-28 to 2025-03-28 | $5.6m | us-gaap:NetIncomeLoss |
| Net income | 6 months2024-09-28 to 2025-03-28 | −$12.5m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2024-12-28 to 2025-03-28 | $0.06 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2024-09-28 to 2025-03-28 | −$0.05 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2024-12-28 to 2025-03-28 | $0.06 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2024-09-28 to 2025-03-28 | −$0.05 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2024-12-28 to 2025-03-28 | 122,624,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2024-09-28 to 2025-03-28 | 123,156,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2024-09-28 to 2025-03-28 | $11.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2024-09-28 to 2025-03-28 | $27.6m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 6 months2024-09-28 to 2025-03-28 | $75.9m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 6 months2024-09-28 to 2025-03-28 | $552.4m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2025-03-28 | $1.20bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2025-03-28 | $4.44bn | us-gaap:AssetsCurrent |
| Total assets | At period end2025-03-28 | $11.21bn | us-gaap:Assets |
| Current liabilities | At period end2025-03-28 | $2.96bn | us-gaap:LiabilitiesCurrent |
| Long-term debt | At period end2025-03-28 | $2.63bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2025-03-28 | $0 | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2025-03-28 | $3.86bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000052988-25-000028. Last ingested by Listed: Nov 15, 2026, 00:35 ET. Listed shows no prices and gives no investment advice.